Food and Drug Administration Amendments Act of 2007
E167140
The Food and Drug Administration Amendments Act of 2007 is a U.S. law that expanded the FDA’s authority over drug and device safety, clinical trials, and post-market surveillance, while enhancing transparency and user fee programs.
All labels observed (4)
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
United States federal statute
ⓘ
health law ⓘ |
| abbreviation | FDAAA ⓘ |
| aimsTo |
enhance FDA resources through user fees
ⓘ
improve device safety monitoring ⓘ improve drug safety monitoring ⓘ increase transparency of clinical research ⓘ strengthen post-market surveillance ⓘ |
| amends | Federal Food, Drug, and Cosmetic Act ⓘ |
| containsProvision |
active risk communication to healthcare professionals
ⓘ
drug labeling safety updates ⓘ pediatric research incentives ⓘ post-market risk identification and analysis system ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| creates |
FDA Risk Evaluation and Mitigation Strategies authority
ⓘ
FDA authority to mandate clinical trial registration ⓘ FDA authority to mandate clinical trial results reporting ⓘ FDA authority to require post-marketing clinical trials ⓘ FDA authority to require post-marketing studies ⓘ FDA authority to require safety-related labeling changes ⓘ FDA authority to restrict distribution of certain drugs ⓘ |
| effectiveIn |
United States of America
ⓘ
surface form:
United States
|
| enactedBy | 110th United States Congress ⓘ |
| establishes | ClinicalTrials.gov results reporting requirements ⓘ |
| establishesProgram |
Food and Drug Administration Safety and Innovation Act of 2012
ⓘ
surface form:
Medical Device User Fee and Modernization Act reauthorization
Prescription Drug User Fee Act of 1992 ⓘ
surface form:
Prescription Drug User Fee Act reauthorization
pediatric drug user fee program ⓘ |
| expandsAuthorityOf |
Food and Drug Administration
ⓘ
surface form:
U.S. Food and Drug Administration
|
| hasSection |
Food and Drug Administration Amendments Act of 2007
self-linksurface differs
ⓘ
surface form:
Title II—Medical Device User Fee Amendments of 2007
Food and Drug Administration Amendments Act of 2007 self-linksurface differs ⓘ
surface form:
Title I—Prescription Drug User Fee Amendments of 2007
Title VIII—Clinical Trial Databases ⓘ |
| legalDomain |
food and drug law
ⓘ
public health law ⓘ |
| primaryAgencyAffected |
Food and Drug Administration
ⓘ
surface form:
U.S. Food and Drug Administration
|
| publicLawNumber | Public Law 110-85 ⓘ |
| regulates |
biological products
ⓘ
clinical trials of drugs and devices ⓘ medical devices ⓘ prescription drugs ⓘ |
| shortName |
Food and Drug Administration Amendments Act of 2007
self-linksurface differs
ⓘ
surface form:
FDA Amendments Act of 2007
|
| signedBy | George W. Bush ⓘ |
| signingDate | 2007-09-27 ⓘ |
| subjectOf |
clinical trial transparency
ⓘ
device safety ⓘ drug safety ⓘ post-market surveillance ⓘ |
| title | An Act to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish a user-fee program for pediatric drugs, and for other purposes ⓘ |
| yearEnacted | 2007 ⓘ |
Referenced by (5)
Full triples — surface form annotated when it differs from this entity's canonical label.
Federal Food, Drug, and Cosmetic Act
→
amendedBy
→
Food and Drug Administration Amendments Act of 2007
ⓘ
Food and Drug Administration Amendments Act of 2007
→
shortName
→
Food and Drug Administration Amendments Act of 2007
self-linksurface differs
ⓘ
this entity surface form:
FDA Amendments Act of 2007
Food and Drug Administration Amendments Act of 2007
→
hasSection
→
Food and Drug Administration Amendments Act of 2007
self-linksurface differs
ⓘ
this entity surface form:
Title I—Prescription Drug User Fee Amendments of 2007
Food and Drug Administration Amendments Act of 2007
→
hasSection
→
Food and Drug Administration Amendments Act of 2007
self-linksurface differs
ⓘ
this entity surface form:
Title II—Medical Device User Fee Amendments of 2007